Sensei Biotherapeutics (SNSE) has the highest short interest by a US stock in the Biotechnology Industry, with 92.38% of float sold short (855,820 shares).
| ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
|---|---|---|---|---|
Sensei Biotherapeutics (SNSE) | 855,820 | 810,857 | 92.38% | 12.01 |
Virax Biolabs Group Limited Ordinary Shares (VRAX) | 5.0069M | 6.4261M | 71.68% | .14 |
Monopar Therapeutics (MNPR) | 1.7232M | 4.3968M | 68.61% | 8.63 |
LENZ Therapeutics (LENZ) | 9.4779M | 18.4821M | 51.98% | 8.13 |
ARS Pharmaceuticals (SPRY) | 26.7646M | 41.0356M | 43.79% | 16.85 |
Kalvista Pharmaceuticals (KALV) | 19.6453M | 29.5333M | 43.08% | 17.13 |
Replimune (REPL) | 18.426M | 62.9013M | 39.99% | 2.63 |
Immunitybio (IBRX) | 140.326M | 377.7075M | 37.06% | 6.18 |
Intellia Therapeutics (NTLA) | 38.812M | 111.9386M | 36.77% | 12.41 |
Recursion Pharmaceuticals (RXRX) | 174.3978M | 510.2892M | 34.94% | 14 |
Beam Therapeutics (BEAM) | 22.221M | 87.9232M | 33.53% | 10.36 |
Arcturus Therapeutics (ARCT) | 6.2519M | 26.2836M | 33.2% | 11.9 |
Onconetix (ONCO) | 228,855 | 653,838 | 33.12% | .01 |
Neurogene (NGNE) | 4.0118M | 5.1298M | 32.17% | 26.23 |
Rallybio (RLYB) | 1.4058M | 3.1619M | 31.98% | 15.3 |
Sellas Life Sciences (SLS) | 56.6422M | 178.7852M | 30.83% | 8.28 |
Abeona Therapeutics (ABEO) | 16.47M | 42.4729M | 30.68% | 11.22 |
Twist Bioscience (TWST) | 14.5221M | 54.6501M | 30.52% | 12.19 |
Organogenesis (ORGO) | 13.0987M | 57.977M | 28.85% | 6.81 |
Novavax (NVAX) | 46.3372M | 140.2177M | 28.54% | 12.37 |
Iovance Biotherapeutics (IOVA) | 108.804M | 353.4507M | 28.41% | 7.75 |
Tango Therapeutics (TNGX) | 40.245M | 68.4449M | 28.27% | 12.82 |
Absci (ABSI) | 35.0862M | 143.2799M | 28.1% | 7.88 |
Sarepta Therapeutics (SRPT) | 25.3344M | 92.8834M | 27.97% | 7.67 |
Sana Biotechnology (SANA) | 40.8789M | 179.6921M | 27.62% | 11.37 |
Historical short interest data is not available.